The global orthobiologics industry, valued at USD 6.0 billion in 2023, is projected to grow at a steady compound annual growth rate (CAGR) of 3.0% during the forecast period, reaching USD 8.1 billion by 2033. This growth highlights the increasing adoption of orthobiologic products in treating musculoskeletal disorders and enhancing bone healing and regeneration.
Orthobiologics, including bone grafts, stem cells, and growth factors, are gaining traction due to their ability to improve surgical outcomes and reduce recovery time. With an aging global population and the rising prevalence of orthopedic conditions, such as arthritis and osteoporosis, the demand for advanced treatments is set to rise.
Moreover, ongoing advancements in biomaterials and regenerative medicine are paving the way for innovative orthobiologic products. These developments are expected to further fuel market growth as healthcare providers and patients increasingly seek effective, minimally invasive solutions.
Full Report Revealed – https://www.futuremarketinsights.com/reports/orthobiologics-market
Key Takeaways:
- The orthobiologics market is forecasted to grow at a 3.0% CAGR, reaching $8.1 billion by 2033.
- Rising prevalence of musculoskeletal disorders and orthopedic conditions drives demand.
- Advancements in biomaterials and regenerative medicine enhance product innovation.
- Orthobiologics are preferred for their ability to improve surgical outcomes and expedite recovery.
Market Drivers
- Increasing Incidence of Bone-Related Disorders: A rise in conditions such as osteoarthritis and other bone injuries is driving demand for orthobiologics, which are used in treatments to promote healing and recovery.
- Advancements in Medical Technology: Continuous innovations in orthobiologics, including new formulations and delivery methods, are enhancing treatment efficacy and safety.
- Growing Geriatric Population: An aging population that is more susceptible to musculoskeletal disorders is contributing to the increased demand for orthobiologic products.
- Rising Number of Surgical Procedures: The growing volume of orthopedic surgeries is expected to boost the adoption of orthobiologics in clinical settings.
Challenges
- Regulatory Hurdles: Stringent regulatory requirements for product approval can slow down the introduction of new orthobiologic therapies into the market.
- Cost Considerations: High costs associated with some orthobiologic treatments may limit their accessibility for certain patient populations.
Competition Scenario
The market players are focusing on creating advanced products that provide ease to patients. The research and development programs that deliver products to support the patient in their overall recovery process are another factor competitors focus on. This involves the integration of regenerative medicine, alternative therapies, and bone support products.
Latest Developments:
- Medtronic extends the product list with balloon kyphoplasty, tumor management, vertebroplasty, sports surgery, nucleus removal tools, and SpineLine reimbursement. These extensions are helping the hospital facilities along with the introduction of electrosurgical products.
- In 2023, Zimmer Biomet acquired embody, an orthobiologics company for US$ 155 million. The company focuses on soft tissue healing and enhanced pipeline area. The acquisition will enhance the supply chain and distribution channel.
Key Contributors of the Orthobiologics Market are
- Medtronic (Ireland)
- Zimmer Biomet
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Stryker
- Anika Therapeutics, Inc.
- SeaSpine
- Bioventus
- RTI Surgical
- MTF Biologics
- Arthrex, Inc.
- Smith & Nephew
Key Segments
By Product Type:
- Bone Growth Stimulators (BGS)
- Non-invasive Electrical BGS
- Invasive Electrical BGS
- Ultrasound BGS
- Viscosupplements
- Single Injection Viscosupplements
- Three Injection Viscosupplements
- Five Injection Viscosupplements
- Bone Graft Substitute
- Allografts
- Synthetics
- Xenografts
- Bone Morphogenetic Protein
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedics Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Scar Treatment Market
Mesotherapy Market
Age Related Vision Dysfunction Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube